Belite Bio (BLTE) Interest Expenses (2024 - 2025)

Belite Bio's Interest Expenses history runs 7 years deep, the most recent figure standing at -$13.2 million for Q1 2026.

• In Q1 2026, Interest Expenses fell 297.84% year-over-year to -$13.2 million; the TTM figure through Mar 2026 stood at -$1.5 million (down 160.11% YoY), while the FY2025 annual figure was $359.7 million, up 31.58% from the prior year.
• Interest Expenses for Q1 2026 stood at -$13.2 million, down from $11.7 million in the prior quarter.
• The five-year high for Interest Expenses was $11.7 million in Q4 2025, with the low at -$13.2 million in Q1 2026.
• The 5-year median for Interest Expenses is $3.5 million (2023), against an average of $2.0 million.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses plunged 1312.1% in 2024, then jumped 378.53% in 2025.
• Belite Bio's Interest Expenses stood at $10.5 million in 2022, then slumped by 96.69% to $347000.0 in 2023, then slumped by 1312.1% to -$4.2 million in 2024, then surged by 378.53% to $11.7 million in 2025, then plunged by 212.64% to -$13.2 million in 2026.
• Business Quant data shows BLTE's Interest Expenses at -$13.2 million in Q1 2026, $11.7 million in Q4 2025, and $6.7 million in Q1 2025.